Chiari Kojima

512 total citations
25 papers, 394 citations indexed

About

Chiari Kojima is a scholar working on Nephrology, Hematology and Immunology. According to data from OpenAlex, Chiari Kojima has authored 25 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 7 papers in Hematology and 6 papers in Immunology. Recurrent topics in Chiari Kojima's work include Renal Diseases and Glomerulopathies (9 papers), Platelet Disorders and Treatments (5 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). Chiari Kojima is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Platelet Disorders and Treatments (5 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). Chiari Kojima collaborates with scholars based in Japan, United Kingdom and Sweden. Chiari Kojima's co-authors include Kosaku Nitta, Takashi Takei, Mitsuyo Itabashi, Masayuki Yoshida, Keiko Uchida, Takahito Moriyama, Tetsuya Ogawa, Yuki Tsuruta, Hidekazu Sugiura and Ken Tsuchiya and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, Journal of Pharmacology and Experimental Therapeutics and Nephrology Dialysis Transplantation.

In The Last Decade

Chiari Kojima

24 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiari Kojima Japan 13 220 100 84 76 68 25 394
Giuseppina Cerullo Italy 11 306 1.4× 94 0.9× 101 1.2× 62 0.8× 90 1.3× 14 528
Kiichiro Jinde Japan 12 354 1.6× 86 0.9× 42 0.5× 65 0.9× 40 0.6× 19 624
Thilo Krueger Germany 7 263 1.2× 30 0.3× 78 0.9× 55 0.7× 130 1.9× 8 641
Gopala K. Rangan Australia 10 285 1.3× 141 1.4× 33 0.4× 60 0.8× 21 0.3× 13 481
Chun-Gyoo Ihm South Korea 11 199 0.9× 54 0.5× 24 0.3× 64 0.8× 24 0.4× 16 428
Edith Bigot France 9 265 1.2× 83 0.8× 34 0.4× 82 1.1× 42 0.6× 15 478
Songxia Quan China 11 302 1.4× 123 1.2× 23 0.3× 67 0.9× 23 0.3× 22 430
Alice Sue Appel United States 7 217 1.0× 33 0.3× 29 0.3× 52 0.7× 44 0.6× 8 387
Helen Lovell United States 7 703 3.2× 132 1.3× 105 1.3× 144 1.9× 45 0.7× 8 833
M Merta Czechia 14 207 0.9× 29 0.3× 48 0.6× 49 0.6× 46 0.7× 48 547

Countries citing papers authored by Chiari Kojima

Since Specialization
Citations

This map shows the geographic impact of Chiari Kojima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiari Kojima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiari Kojima more than expected).

Fields of papers citing papers by Chiari Kojima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiari Kojima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiari Kojima. The network helps show where Chiari Kojima may publish in the future.

Co-authorship network of co-authors of Chiari Kojima

This figure shows the co-authorship network connecting the top 25 collaborators of Chiari Kojima. A scholar is included among the top collaborators of Chiari Kojima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiari Kojima. Chiari Kojima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kojima, Chiari, Hiroshi Umemura, Tatsuo Shimosawa, & Tomohiro Nakayama. (2023). Sex differences in the evaluation of proteinuria using the urine dipstick test. Frontiers in Medicine. 10. 1148698–1148698.
2.
Sato, Ryohei, et al.. (2023). Variation in antibody titers determined by Abbott and Roche Elecsys SARS-CoV-2 assays in vaccinated healthcare workers. Heliyon. 9(6). e16547–e16547. 1 indexed citations
3.
Khamis, Ramzi, Adam Hartley, Chiari Kojima, et al.. (2022). Monoclonal Autoantibody Against a Cryptic Epitope on Tissue-Adherent Low-Density Lipoprotein for Molecular Imaging in Atherosclerosis. JACC. Cardiovascular imaging. 15(8). 1458–1470. 2 indexed citations
4.
5.
6.
Kojima, Chiari, Kazuho Honda, Ari Shimizu, et al.. (2015). Combined IgG4κ and IgG1λ deposition in the glomerular and tubular basement membrane accompanied by autoimmune neutropenia (AIN) and immune thrombocytopenia (ITP). CEN Case Reports. 4(2). 206–211. 3 indexed citations
7.
Takei, Takashi, Mitsuyo Itabashi, Takahito Moriyama, et al.. (2012). Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults. Nephrology Dialysis Transplantation. 28(5). 1225–1232. 55 indexed citations
8.
Moriyama, Takahito, Yuki Tsuruta, Chiari Kojima, et al.. (2011). Beneficial effect of aliskiren combined with olmesartan in reducing urinary protein excretion in patients with chronic kidney disease. International Urology and Nephrology. 44(3). 841–845. 17 indexed citations
9.
Takei, Takashi, et al.. (2011). Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome. Clinical and Experimental Nephrology. 15(6). 933–936. 10 indexed citations
10.
Moriyama, Takahito, Ayami Ochi, Yuki Tsuruta, et al.. (2011). Long-term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patients with advanced immunoglobulin A nephropathy and impaired renal function. Clinical and Experimental Nephrology. 15(5). 700–707. 13 indexed citations
11.
Ochi, Ayami, Takashi Takei, Chiari Kojima, et al.. (2011). A case of acute renal failure after exercise with renal hypouricemia demonstrated compound heterozygous mutations of uric acid transporter 1. Clinical and Experimental Nephrology. 16(2). 316–319. 8 indexed citations
12.
13.
Kojima, Chiari, et al.. (2010). MMP-9 Inhibition by ACE Inhibitor Reduces Oxidized LDL-Mediated Foam-Cell Formation. Journal of Atherosclerosis and Thrombosis. 17(1). 97–105. 19 indexed citations
14.
Sugiura, Hidekazu, Takashi Takei, Mitsuyo Itabashi, et al.. (2010). Effect of Single-Dose Rituximab on Primary Glomerular Diseases. Nephron Clinical Practice. 117(2). c98–c105. 46 indexed citations
15.
Itabashi, Mitsuyo, Chiari Kojima, Kunio Kawanishi, et al.. (2009). Successful therapeutic use of a single-dose of rituximab on relapse in adults with minimal change nephrotic syndrome. Clinical Nephrology. 72(7). 69–72. 19 indexed citations
16.
Kojima, Chiari, Akio Kawakami, Takashi Takei, Kosaku Nitta, & Masayuki Yoshida. (2007). Angiotensin-Converting Enzyme Inhibitor Attenuates Monocyte Adhesion to Vascular Endothelium through Modulation of Intracellular Zinc. Journal of Pharmacology and Experimental Therapeutics. 323(3). 855–860. 19 indexed citations
17.
Mori, Daisuke, Hideto Ishii, Chiari Kojima, et al.. (2007). Cilostazol Inhibits Monocytic Cell Adhesion to Vascular Endothelium Via Upregulation of cAMP. Journal of Atherosclerosis and Thrombosis. 14(5). 213–218. 18 indexed citations
18.
Takei, Takashi, Koichi Suzuki, Satsuki Shirota, et al.. (2007). The characteristics of relapse in adult-onset minimal-change nephrotic syndrome. Clinical and Experimental Nephrology. 11(3). 214–217. 27 indexed citations
19.
Kojima, Chiari, Wako Yumura, Mitsuyo Itabashi, et al.. (2005). [A case of microscopic polyangitis with sepsis due to pyelonephritis].. PubMed. 47(8). 876–81. 3 indexed citations
20.
Iho, Sumiko, et al.. (1980). [Studies on the determination of IgG-Fc receptor bearing cells and T gamma-cells of human lymphocytes--with a special reference to the comparison of EA rosette method and double rosette methods (author's transl)].. PubMed. 28(6). 591–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppina Cerullo Breakdown of academic impact, for papers by Kiichiro Jinde Breakdown of academic impact, for papers by Thilo Krueger Breakdown of academic impact, for papers by Gopala K. Rangan Breakdown of academic impact, for papers by Chun-Gyoo Ihm Breakdown of academic impact, for papers by Edith Bigot Breakdown of academic impact, for papers by Songxia Quan Breakdown of academic impact, for papers by Alice Sue Appel Breakdown of academic impact, for papers by Helen Lovell Breakdown of academic impact, for papers by M Merta
Rankless by CCL
2026